Skip to main content

Table 1 Comparison of bone marrow aspiration analyses before and after therapy

From: A novel BCR-ABL1 fusion gene with genetic heterogeneity indicates a good prognosis in a chronic myeloid leukemia case

Cell type

Cell count (%)

Reference

(Mean ± sem)

Before therapy

After therapy

Myeloblast

0.64 ± 0.33

1.5

0

Promyelocyte

1.57 ± 0.60

1.0

0

Neutrophil

 N.myelocyte

6.49 ± 2.04

7.0

1

 N.metamyelocyte

7.90 ± 1.97

6.5

1

 N. band

23.72 ± 3.50

33.0

20

 Neutrophil

9.44 ± 2.92

28.0

45

Eosinophil

0.86 ± 0.61

10.5

7

Basophil

0.03 ± 0.05

3.5

0

Lymphocyte

22.78 ± 7.04

4.0

20

Monocyte

3.00 ± 0.88

0

3